Results

Total Results: 2,231 records

Showing results for "medication".
Users also searched for: medication reconciliation

161. U.S. Preventive Services Task Force Issues Draft Recommendation Statement on Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/gon-news-bulletin.pdf
     October 09, 2018 - The only medication approved by the U.S. … “This medication is safe for babies and treatment can prevent blindness.” … consequences, the Task Force reaffirms that all newborns should continue to receive this important preventive medication

162. Final Recommendation Statement: Folic Acid Supplementation for the Prevention of Neural Tube Defects | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/final-recommendation-statement-folic-acid-supplementation-prevention-neural-tube-defects
     March 09, 2024 - www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication

163. Public Comment on Draft Recommendation: Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/public-comment-draft-recommendation-menopausal-hormone-therapy-primary-prevention-chronic-conditions
     May 29, 2012 - recommendation statement is based on, go to /uspstf/recommendation/menopausal-hormone-therapy-preventive-medication

164. Evidence Summary: Vitamin Supplementation to Prevent Cancer and CVD: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary21/vitamin-supplementation-to-prevent-cancer-and-cvd-counseling
     February 03, 2014 - Evidence Summary Vitamin Supplementation to Prevent Cancer and CVD: Preventive Medication February … The control group in a placebo-controlled trial of medications is not exposed to the medication.

165. Recommendation: Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/vitamin-d-calcium-or-combined-supplementation-for-the-primary-prevention-of-fractures-in-adults-preventive-medication
     April 17, 2018 - Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication … Supplementation for the Primary Prevention of Falls and Fractures in Community-Dwelling Adults: Preventive Medication … Preventive Medication The recommendation against supplementation at lower doses was based on an overall … Harms of Preventive Medication The USPSTF found adequate evidence that supplementation with vitamin … Effectiveness of Preventive Medication The USPSTF reviewed evidence from 8 randomized clinical trials

166. Archived: Final Research Plan: Folic Acid for the Prevention of Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan108/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication-january-2017
     October 16, 2014 - archived Final Research Plan Folic Acid for the Prevention of Neural Tube Defects: Preventive Medication

167. Opportunity for Public Comment | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/public-comments-and-nominations/opportunity-for-public-comment
     April 24, 2025 - PM EDT Draft Evidence Review Perinatal Depression: Preventive Interventions Preventive medication … Draft Recommendation Statement Perinatal Depression: Preventive Interventions Preventive medication

168. Archived: Evidence Summary: Glaucoma: Screening, 2004 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/glaucoma-screening-2004
     March 07, 2005 - CNTGS was a fair-quality trial comparing surgery and topical medication with no treatment in one eye … In the EMGT study, treated patients received medication and/or underwent laser treatment. … In the CNTGS study, patients in the treatment group received either medication, laser treatment, or surgery … ) surgically treated patients developed cataracts compared with 7 of 23 (30%) patients treated with medication … Systemic medication side effects (e.g., cardiovascular or mental) are uncommon. 4 Return to Table

169. Archived: Evidence Summary: Glaucoma: Screening, 2005 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/glaucoma-screening-2005
     March 07, 2005 - CNTGS was a fair-quality trial comparing surgery and topical medication with no treatment in one eye … In the EMGT study, treated patients received medication and/or underwent laser treatment. … In the CNTGS study, patients in the treatment group received either medication, laser treatment, or surgery … ) surgically treated patients developed cataracts compared with 7 of 23 (30%) patients treated with medication … Systemic medication side effects (e.g., cardiovascular or mental) are uncommon. 4 Return to Table

170. Final Research Plan: High Body Mass Index in Children and Adolescents: Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/high-body-mass-index-children-adolescents-interventions
     June 30, 2022 - for a specific group (e.g., cultural, gender, or age [younger children or adolescents] group), and medication … syndrome, Prader-Willi syndrome), asthma, or intellectual and developmental disabilities, or who are using medication … intervention on a different content area) Weight-neutral healthy lifestyle intervention Placebo or no medication … control for medication trials (both groups may include a behavioral weight management component)

171. Final Research Plan: High Body Mass Index in Children and Adolescents: Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/obesity-in-children-and-adolescents-screening
     June 30, 2022 - for a specific group (e.g., cultural, gender, or age [younger children or adolescents] group), and medication … syndrome, Prader-Willi syndrome), asthma, or intellectual and developmental disabilities, or who are using medication … intervention on a different content area) Weight-neutral healthy lifestyle intervention Placebo or no medication … control for medication trials (both groups may include a behavioral weight management component)

172. Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ukSHUEYkZHDnMJVTTxNfeC
     June 01, 2021 - www.uspreventiveservicestaskforce.org/uspstf/draft-update-summary/vitamin-supplementation-to-prevent-cvd-and-cancer-preventive-medication … www.uspreventiveservicestaskforce.org/uspstf/draft-update-summary/vitamin-supplementation-to-prevent-cvd-and-cancer-preventive-medication … www.uspreventiveservicestaskforce.org/uspstf/draft-update-summary/vitamin-supplementation-to-prevent-cvd-and-cancer-preventive-medication

173. Draft Research Plan: Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/weight-loss-prevent-obesity-related-morbidity-mortality
     May 18, 2023 - Pharmacologic interventions (alone or in combination with behavioral-based interventions) vs. placebo or no medication … intervention, including: Any adverse event or serious adverse event Withdrawals or discontinuation of medication … pharmacotherapy): Large nonrandomized studies of interventions comparing concurrent exposure vs. nonexposure to medication

174. Draft Research Plan: Healthy Diet, Physical Activity, and/or Weight Loss to Prevent Cardiovascular Disease in Adults: Behavioral Counseling Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/behavioral-counseling-interventions-promote-healthy-diet-physical-activity-weight-loss-prevent-cardiovascular-disease-adults
     May 18, 2023 - Pharmacologic interventions (alone or in combination with behavioral-based interventions) vs. placebo or no medication … intervention, including: Any adverse event or serious adverse event Withdrawals or discontinuation of medication … pharmacotherapy): Large nonrandomized studies of interventions comparing concurrent exposure vs. nonexposure to medication

175. Draft Recommendation: High Body Mass Index in Children and Adolescents: Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/high-body-mass-index-children-adolescents-interventions
     December 12, 2023 - ., fecal incontinence, flatus, and gall stones), and there is no evidence on the harms of long-term medication … Five trials included behavioral counseling components along with the medication or placebo. … 12 years or older or 14 years or older; one study included children ages 7 to 11 years. 1 Only one medication … The only medication that showed a clear reduction in blood pressure was phentermine/topiramate, and only … No evidence was available on adverse effects beyond 1 month after medication discontinuation, and no

176. Draft Recommendation: Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/folic-acid-supplementation-prevent-neural-tube-defects
     February 21, 2023 - Draft Recommendation Statement Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication … Update in Progress for Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication … Low levels of maternal folate may be due to inadequate dietary intake, poor intestinal absorption, medication

177. Evidence Summary: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication
     September 28, 2021 - Evidence Summary Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication … adherence in the trials was the number of women who were found to be taking at least 80% of their treatment medication … statement: low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: preventive medication … RecommendationStatementFinal/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication … Gastroschisis in Europe—a case-malformed-control study of medication and maternal illness during pregnancy

178. U.S. Preventive Services Task Force Issues Final Recommendation Statement on Medications to Reduce Breast Cancer Risk (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/breast-cancer-meds-final-rec-news-bulletin.pdf
     September 03, 2019 - risk-reducing medications to women who are at increased risk for breast cancer and at low risk for adverse medication … The severity of these harms can vary by the specific medication and a woman’s risk factors for these

179. Archived: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
     April 11, 2016 - Recommendation Statement Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication … Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication … Preventive Medication Aspirin's anticlotting effect is useful for primary and secondary CVD prevention … The complexity of risk factors, medication use, and concomitant illness make it difficult to assess the … Preferences about taking aspirin: Persons who place a high value on avoiding long-term daily medication

180. Public Comment on Draft Recommendation Statement and Draft Evidence Review: Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/public-comment-draft-recommendation-statement-and-draft-evidence-review-ocular-prophylaxis-gonococcal-ophthalmia-neonatorum
     October 09, 2018 - After reviewing the evidence, the Task Force recommends prophylactic ocular topical medication for all